Publications by authors named "Catherine A A Beauchemin"

Claim this Profile
E
Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays.
Ankit Srivastava, Qinlu Wang, Christina D Orrù, Manel Fernandez, Yaroslau Compta, Catherine A A Beauchemin

PLoS Pathog· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical parameter identifiability and handling of censored data with Bayesian inference in mathematical tumour models.
Jamie Porthiyas, Daniel Nussey, Catherine A A Beauchemin, Donald C Warren, Christian Quirouette

NPJ Syst Biol Appl· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1.
Karen Y Y Fung, Tse Wing Winnie Ho, Zizhen Xu, Dante Neculai, Catherine A A Beauchemin

J Lipid Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring associations between viral titer measurements and disease outcomes in ferrets inoculated with 125 contemporary influenza A viruses.
Troy J Kieran, Xiangjie Sun, Taronna R Maines, Catherine A A Beauchemin, Jessica A Belser

J Virol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of random virus failure following cell entry on infection outcome and the success of antiviral therapy.
Christian Quirouette, Daniel Cresta, Jizhou Li, Kathleen P Wilkie, Haozhao Liang, Catherine A A Beauchemin

Sci Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of Human Data in Risk Assessments of Influenza A Virus Using the Ferret Model.
Hannah M Creager, Troy J Kieran, Hui Zeng, Xiangjie Sun, Joanna A Pulit-Penaloza, Catherine A A Beauchemin

J Virol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample's infection concentration.
Daniel Cresta, Donald C Warren, Christian Quirouette, Amanda P Smith, Lindey C Lane, Catherine A A Beauchemin

PLoS Comput Biol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract.
Christian Quirouette, Nada P Younis, Micaela B Reddy, Catherine A A Beauchemin

PLoS Comput Biol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample's infection concentration.
Daniel Cresta, Donald C Warren, Christian Quirouette, Amanda P Smith, Lindey C Lane, Catherine A A Beauchemin

PLoS Comput Biol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying mechanistic traits of influenza viral dynamics using in vitro data.
Ada W C Yan, Jie Zhou, Catherine A A Beauchemin, Colin A Russell, Wendy S Barclay

Epidemics· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract.
Christian Quirouette, Nada P Younis, Micaela B Reddy, Catherine A A Beauchemin

PLoS Comput Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Ebola virus replication kinetics in vitro.
Laura E Liao, Jonathan Carruthers, Sophie J Smither, , Simon A Weller, Catherine A A Beauchemin

PLoS Comput Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract.
Christian Quirouette, Nada P Younis, Micaela B Reddy, Catherine A A Beauchemin

PLoS Comput Biol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses.
Catherine A A Beauchemin, Young-In Kim, Qin Yu, Giuseppe Ciaramella, John P DeVincenzo

PLoS One· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling endurance and resumption times for repetitive one-hand pushing.
Linda M Rose, Catherine A A Beauchemin, W Patrick Neumann

Ergonomics· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors.
Laura E Liao, Szymon Kowal, Daniel A Cardenas, Catherine A A Beauchemin

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.
Hana M Dobrovolny, Catherine A A Beauchemin

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of SHIV production by infected cells is not exponentially distributed: Implications for estimates of infection parameters and antiviral efficacy.
Catherine A A Beauchemin, Tomoyuki Miura, Shingo Iwami

Sci Rep· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients.
John Palmer, Hana M Dobrovolny, Catherine A A Beauchemin

Sci Rep· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(In)validating experimentally derived knowledge about influenza A defective interfering particles.
Laura E Liao, Shingo Iwami, Catherine A A Beauchemin

J R Soc Interface· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility.
Eric G Paradis, Lady Tatiana Pinilla, Benjamin P Holder, Yacine Abed, Guy Boivin, Catherine A A Beauchemin

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses.
Philippe F Simon, Marc-Antoine de La Vega, Éric Paradis, Emelissa Mendoza, Kevin M Coombs, Catherine A A Beauchemin

Sci Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression.
Mohamed A Kamal, Ronald Gieschke, Annabelle Lemenuel-Diot, Catherine A A Beauchemin, Patrick F Smith

Antimicrob Agents Chemother· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression.
Mohamed A Kamal, Ronald Gieschke, Annabelle Lemenuel-Diot, Catherine A A Beauchemin, Patrick F Smith

Antimicrob Agents Chemother· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain.
Yusuke Kakizoe, Shinji Nakaoka, Catherine A A Beauchemin, Satoru Morita, Hiromi Mori

Sci Rep· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis